ADVAIR
ADVAIR
Approved
DIN Number
02245126
Drug Class
Human
Market Date
Dec 21, 2001
Company
HC
GlaxoSmithKline Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02245126
AIG Number0238341005
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
R03AK06 SALMETEROL AND FLUTICASONE
Product Specifications
Dosage FormAerosol, Metered Dose
Route of AdministrationInhalation
AHFS Classification68:04.00
Health Canada Classification
ACTIVE INGREDIENTS (2)
FLUTICASONE PROPIONATEActive
Strength: 125 MCG / ACT
Monograph: FLUTICASONE PROPIONATE
SALMETEROL (SALMETEROL XINAFOATE)Active
Strength: 25 MCG / ACT
Monograph: SALMETEROL (SALMETEROL XINAFOATE)